These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22362330)

  • 21. Psychosis in Parkinson's disease: case studies.
    Salter BC; Anderson KE; Weiner WJ
    Neurol Clin; 2006 May; 24(2):363-9. PubMed ID: 16684637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychosis in Parkinson's disease.
    Thanvi BR; Lo TC; Harsh DP
    Postgrad Med J; 2005 Oct; 81(960):644-6. PubMed ID: 16210460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT
    Huot P
    Neurodegener Dis Manag; 2018 Dec; 8(6):363-365. PubMed ID: 30451579
    [No Abstract]   [Full Text] [Related]  

  • 24. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic agents.
    Ghate VR
    N C Med J; 1973 Nov; 34(11):859-65. PubMed ID: 4149848
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of behavioural symptoms and dementia in Parkinson's disease.
    Hanagasi HA; Emre M
    Fundam Clin Pharmacol; 2005 Apr; 19(2):133-46. PubMed ID: 15810893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of Parkinson's disease associated with psychosis].
    Ombrato M; Capone D
    Clin Ter; 1975 Aug; 74(3):293-7. PubMed ID: 1227749
    [No Abstract]   [Full Text] [Related]  

  • 28. Management of hallucinations and psychosis in Parkinson's disease.
    Eng ML; Welty TE
    Am J Geriatr Pharmacother; 2010 Aug; 8(4):316-30. PubMed ID: 20869621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinson's disease psychosis 2010: a review article.
    Friedman JH
    Parkinsonism Relat Disord; 2010 Nov; 16(9):553-60. PubMed ID: 20538500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rebound psychosis: effect of discontinuation of antipsychotics in Parkinson's disease.
    Fernandez HH; Trieschmann ME; Okun MS
    Mov Disord; 2005 Jan; 20(1):104-5. PubMed ID: 15390047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Psychosis in Parkinson's disease.
    Wint DP; Okun MS; Fernandez HH
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):127-36. PubMed ID: 15312276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of psychotic complications of Parkinson disease with clozapine].
    Ozsancak C; Auzou P; Ronzière T; Hannequin D; Augustin P
    Presse Med; 1997 Nov; 26(33):1599-602. PubMed ID: 9452762
    [No Abstract]   [Full Text] [Related]  

  • 33. Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients.
    Christensen I; Geismar L; Kirkegaard A; Kirkegaard G
    Arzneimittelforschung; 1986 May; 36(5):855-60. PubMed ID: 2873821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute psychosis.
    Adler G
    N Engl J Med; 1974 Jul; 291(2):81-3. PubMed ID: 4151710
    [No Abstract]   [Full Text] [Related]  

  • 35. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Psychosis in Parkinson's disease and sudden death.
    Kyle K; Bronstein JM
    Parkinsonism Relat Disord; 2020 Oct; 79():127. PubMed ID: 32943345
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of quetiapine in psychotic Parkinson's disease patients: a double-blind labeled study of 3 months' duration.
    Rabey JM; Prokhorov T; Miniovitz A; Dobronevsky E; Klein C
    Mov Disord; 2007 Feb; 22(3):313-8. PubMed ID: 17034006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychosis in elderly patients: classification and pharmacotherapy.
    Mintzer J; Targum SD
    J Geriatr Psychiatry Neurol; 2003 Dec; 16(4):199-206. PubMed ID: 14653427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of quetiapine fumarate on drug-induced psychosis in patients with Parkinson's disease].
    Kohmoto J; Kihira T; Miwa H; Kondo T
    No To Shinkei; 2002 Jun; 54(6):489-92. PubMed ID: 12166098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pimavanserin for Parkinson Disease Psychosis.
    Mohanty D; Sarai S; Naik S; Lippmann S
    Prim Care Companion CNS Disord; 2019 Apr; 21(2):. PubMed ID: 31050230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.